TANG CAPITAL MANAGEMENT, LLC 13D and 13G filings for Marinus Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-02-14 4:00 pm Sale | 2024-12-31 | 13G | Marinus Pharmaceuticals, Inc. MRNS | TANG CAPITAL MANAGEMENT, LLC | 1,641,945 3.000% | -2,860,912 (-63.54%) | Filing |
| 2024-04-19 06:04 am Purchase | 2024-04-16 | 13G | Marinus Pharmaceuticals, Inc. MRNS | TANG CAPITAL MANAGEMENT, LLC | 4,502,857 8.200% | 4,502,857 (New Position) | Filing |